| Name | SARS-CoV-2-IN-21 |
|---|
| Description | SARS-CoV-2-IN-21 (compound 10), a penicillin sulfone benzyl C6 derivative, is a potent SARS-CoV-2 main protease inhibitor, with an IC50 of 5.3 μM. SARS-CoV-2-IN-21 can be used for COVID-19 research[1]. |
|---|---|
| Related Catalog | |
| Target |
IC50: 5.3 ± 3.3 μM (SARS-CoV-2 main protease)[1] |
| References |
| Molecular Formula | C23H24N2O7S |
|---|---|
| Molecular Weight | 472.51 |